Clinically significant or uncontrolled cardiac disease.
Serious co-morbid medical conditions, including clinically-significant cardiac disease
Clinically significant cardiac disease.
History of clinically significant cardiac disease; uncontrolled hypertension
Clinically significant cardiac disease
History of significant cardiac disease or uncontrolled hypertension
History of significant cardiac disease, cardiac risk factors, or uncontrolled arrhythmias
EXCLUSION CRITERIA FOR REGISTRATION: History of significant cardiac disease, cardiac risk factors, or uncontrolled arrhythmias
Clinically significant cardiac disease.
Clinically significant, uncontrolled heart disease and/or recent cardiac event (within  months prior to randomization)
Active or clinically significant cardiac disease.
History of clinically significant or uncontrolled cardiac disease including but not limited to:
Patients must not have clinically significant cardiac disease.
Clinically significant cardiac disease
Documented clinically significant cardiac arrhythmias
Have a significant cardiac condition.
Active or clinically significant cardiac disease
clinically significant cardiac disease
Subjects with clinically significant uncontrolled cardiac disease
Clinically significant cardiac disease
Evidence or history of significant cardiac disease (including evidence or history of significant cardiac disease (including myocardial infarction [MI] in the past  months, significant cardiac arrhythmia, stage III or IV congestive heart failure [CHF]); cardiac stress test will be done as clinically indicated; (the specific test to be chosen at the discretion of the principal investigator [PI])
Patients who have a history of significant cardiac disease, cardiac disease risk factors or uncontrolled arrhythmias are NOT eligible for either Stratum
History or current diagnosis of cardiac disease indicating significant risk of safety for patients participating in the study such as uncontrolled or significant cardiac disease
Uncontrolled clinically significant cardiac arrhythmia
Clinically significant or uncontrolled cardiac disease.
Clinically significant cardiac disease
History of clinically significant cardiac disease
current, serious, clinically significant cardiac arrhythmias as determined by the Investigator.
Clinically significant cardiac disease as per protocol-defined criteria.
Have clinically significant cardiac disease
Subjects with significant cardiac issues
History of significant cardiac disease, cardiac risk factors or uncontrolled arrhythmias
History of significant cardiac disease, cardiac risk factors or uncontrolled arrhythmias
Sustained or clinically significant cardiac arrhythmias
Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality, or clinically significant cardiac arrhythmias
Significant history or risk of cardiac disease
Has clinically significant cardiac disease
History of clinically significant or uncontrolled cardiac, hepatic, or pulmonary disease
Significant active cardiac disease within the previous  months
Significant active cardiac disease within the previous  months prior to signing the ICF, including:
Has clinically significant cardiac disease
Clinically significant cardiac disease
Clinically significant cardiac disease
Significant active cardiac disease within the previous  months from the signing of the ICD, including:
Significant active cardiac disease within the previous  months, including:
Clinically significant, uncontrolled heart disease and/or recent cardiac repolarization abnormality including any of the following:
Clinically significant active cardiac disease, uncontrolled heart disease and/or history of cardiac dysfunction including any of the following
Clinically significant (i.e. active) cardiac disease (e.g. symptomatic coronary artery disease, uncontrolled cardiac arrhythmia, or myocardial infarction within the last  months); any history of clinically significant cardiac failure
Active or clinically significant cardiac disease including:
Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality
Uncontrolled or significant cardiac disease
Clinically significant or uncontrolled hypertension or cardiac disease
Have clinically significant cardiac disease
Clinically significant, uncontrolled heart disease and/or recent cardiac event within  months prior to study
No clinically significant cardiac conduction disorder on screening.
History of clinically significant or uncontrolled cardiac disease.
Significant cardiac disease within  months
Clinically significant valvular heart disease or uncontrollable high-risk cardiac arrhythmia
Clinically significant cardiac disease as defined in the protocol
Clinically significant cardiac disease
Significant cardiac disease
Evidence or history of significant cardiac disease
Clinically significant cardiac disease
Significant cardiac events
History of clinically significant cardiac disease
Clinically significant, uncontrolled heart disease and/or recent cardiac events.
Clinically significant cardiac disease
Clinically significant cardiac disease, including:
Have clinically significant cardiac disease
Clinically significant cardiac disease
Uncontrolled systemic disease (e.g., clinically significant cardiac, pulmonary or metabolic disease)
History of or evidence of clinically significant uncontrolled cardiac arrhythmias
Known significant uncontrolled cardiac arrhythmias
Significant history of cardiac disease
History of clinically significant cardiac disease.
Evidence of clinically significant cardiac abnormalities, uncontrolled hypotension, left ventricular ejection fraction below the lower limit of normal for the site or experience of significant cardiac interventional procedures.
Significant history of cardiac disease
Clinically significant cardiac disease;
Significant active cardiac disease within the previous  months:
History of significant cardiac disease, cardiac risk factors or uncontrolled arrhythmias
Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality, or clinically significant cardiac arrhythmias
Sustained or clinically significant cardiac arrhythmias
Any clinically significant comorbidities, such as uncontrolled pulmonary disease, known impaired cardiac function or clinically significant cardiac disease (specified below), active CNS disease, active infection, or any other condition that could compromise the participant's participation in the study.
Clinically significant cardiac disease
Subjects with clinically significant uncontrolled cardiac disease
Clinically significant cardiac or pulmonary disease
Patients with any known significant cardiac abnormality.
Any significant cardiac, hepatic or renal disease
Significant active cardiac disease within the previous  months, including:
History of clinically significant or uncontrolled cardiac disease.
Clinically significant cardiac disease within last  months
History of clinically significant or active cardiac disease
History of significant cardiac disease or uncontrolled arrhythmias
Clinically significant, uncontrolled heart disease and/or recent cardiac event (within  months